Z.L. Zeng, H.Z. Ding, D. Yang, Y.H. Yang,
The Pharmacodynamic Effects of Amoxicillin Against Staphylococcus aureus in an In-vitro
Kinetic Model,
Journal of Animal and Veterinary Advances,
Volume 15,Issue 11,
2016,
Pages 69-74,
ISSN 1680-5593,
javaa.2016.69.74,
(https://makhillpublications.co/view-article.php?doi=javaa.2016.69.74)
Abstract: The pharmacodynamic effect of amoxycillin
against Staphylococcus aureus was evaluated in an
in-vitro pharmacodynamic model. For amoxycillin peak
concentrations of 0.4, 1.0, 1.6 and 3.2 mg mL1 and
half-lives of 2 and 5.5 h were examined. The bactericidal
effect was measured as the reduction in colony count (log
CFU mL1) during the experimental period and the
overall pharmacodynamic effect as the area under the
bacterial growth versus time curve (AUBC). In an in vitro
model with elimination half-life of 2 h, only 16 MIC
amoxicillin exhibited persistent killing of Staphylococcus
aureu with a bacterial number reduction of 2.51 lo10. in
an in vitro model with simulative elimination half-life of
5.5 h, 5, 8 and 16 MIC amoxicillin exhibited persistent
killing of Staphylococcus aureu with a bacterial number
reduction of 2.42, 2.72 and 2.53 lo10 noted during the
12 h, respectively. These data indicate that amoxicillin
reach the maximum killing at 5-folds of their MIC values
and the antimicrobial maintaining time is mainly
correlated with T>MIC. But during the whole
experimental period, bactericidal effect and bacterial
elimination were not achieved on Staphylococcus aureu
strains for which the MIC was 0.2 μg mL1, even with a
Cmax/MIC ratio of 16.
Keywords: Pharmacodynamic;amoxycillin;effect;experimental period;bactericidal